MXPA05007348A - Derivados de polimeros solubles en agua tiol-selectivos. - Google Patents
Derivados de polimeros solubles en agua tiol-selectivos.Info
- Publication number
- MXPA05007348A MXPA05007348A MXPA05007348A MXPA05007348A MXPA05007348A MX PA05007348 A MXPA05007348 A MX PA05007348A MX PA05007348 A MXPA05007348 A MX PA05007348A MX PA05007348 A MXPA05007348 A MX PA05007348A MX PA05007348 A MXPA05007348 A MX PA05007348A
- Authority
- MX
- Mexico
- Prior art keywords
- thiol
- soluble
- derivatives
- polmer
- selective water
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
- C08G75/00—Macromolecular compounds obtained by reactions forming a linkage containing sulfur with or without nitrogen, oxygen, or carbon in the main chain of the macromolecule
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
- C08G65/00—Macromolecular compounds obtained by reactions forming an ether link in the main chain of the macromolecule
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
- A61K47/59—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyureas or polyurethanes
- A61K47/60—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyureas or polyurethanes the organic macromolecular compound being a polyoxyalkylene oligomer, polymer or dendrimer, e.g. PEG, PPG, PEO or polyglycerol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/62—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being a protein, peptide or polyamino acid
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C319/00—Preparation of thiols, sulfides, hydropolysulfides or polysulfides
- C07C319/02—Preparation of thiols, sulfides, hydropolysulfides or polysulfides of thiols
- C07C319/06—Preparation of thiols, sulfides, hydropolysulfides or polysulfides of thiols from sulfides, hydropolysulfides or polysulfides
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C323/00—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
- C07C323/23—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton
- C07C323/39—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton at least one of the nitrogen atoms being part of any of the groups, X being a hetero atom, Y being any atom
- C07C323/40—Y being a hydrogen or a carbon atom
- C07C323/41—Y being a hydrogen or an acyclic carbon atom
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08F—MACROMOLECULAR COMPOUNDS OBTAINED BY REACTIONS ONLY INVOLVING CARBON-TO-CARBON UNSATURATED BONDS
- C08F22/00—Homopolymers and copolymers of compounds having one or more unsaturated aliphatic radicals each having only one carbon-to-carbon double bond, and at least one being terminated by a carboxyl radical and containing at least one other carboxyl radical in the molecule; Salts, anhydrides, esters, amides, imides or nitriles thereof
- C08F22/36—Amides or imides
- C08F22/38—Amides
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
- C08G65/00—Macromolecular compounds obtained by reactions forming an ether link in the main chain of the macromolecule
- C08G65/02—Macromolecular compounds obtained by reactions forming an ether link in the main chain of the macromolecule from cyclic ethers by opening of the heterocyclic ring
- C08G65/26—Macromolecular compounds obtained by reactions forming an ether link in the main chain of the macromolecule from cyclic ethers by opening of the heterocyclic ring from cyclic ethers and other compounds
- C08G65/2636—Macromolecular compounds obtained by reactions forming an ether link in the main chain of the macromolecule from cyclic ethers by opening of the heterocyclic ring from cyclic ethers and other compounds the other compounds containing sulfur
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
- C08G65/00—Macromolecular compounds obtained by reactions forming an ether link in the main chain of the macromolecule
- C08G65/02—Macromolecular compounds obtained by reactions forming an ether link in the main chain of the macromolecule from cyclic ethers by opening of the heterocyclic ring
- C08G65/32—Polymers modified by chemical after-treatment
- C08G65/329—Polymers modified by chemical after-treatment with organic compounds
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
- C08G65/00—Macromolecular compounds obtained by reactions forming an ether link in the main chain of the macromolecule
- C08G65/02—Macromolecular compounds obtained by reactions forming an ether link in the main chain of the macromolecule from cyclic ethers by opening of the heterocyclic ring
- C08G65/32—Polymers modified by chemical after-treatment
- C08G65/329—Polymers modified by chemical after-treatment with organic compounds
- C08G65/334—Polymers modified by chemical after-treatment with organic compounds containing sulfur
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
- C08G75/00—Macromolecular compounds obtained by reactions forming a linkage containing sulfur with or without nitrogen, oxygen, or carbon in the main chain of the macromolecule
- C08G75/20—Polysulfones
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08L—COMPOSITIONS OF MACROMOLECULAR COMPOUNDS
- C08L2203/00—Applications
- C08L2203/02—Applications for biomedical use
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Polymers & Plastics (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Medicinal Preparation (AREA)
- Polyethers (AREA)
- Peptides Or Proteins (AREA)
- Other Resins Obtained By Reactions Not Involving Carbon-To-Carbon Unsaturated Bonds (AREA)
- Addition Polymer Or Copolymer, Post-Treatments, Or Chemical Modifications (AREA)
- Polymers With Sulfur, Phosphorus Or Metals In The Main Chain (AREA)
Abstract
La presente invencion se refiere a derivados de polimeros solubles en agua, que tienen terminos tiolselectivos adecuados para acoplamiento selectivo a grupos tiol, tal como aquellos contenidos en los residuos cisteina de proteinas.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US43855503P | 2003-01-06 | 2003-01-06 | |
US45508403P | 2003-03-14 | 2003-03-14 | |
PCT/US2004/001190 WO2004063250A1 (en) | 2003-01-06 | 2004-01-06 | Thiol-selective water-soluble polmer derivatives |
Publications (1)
Publication Number | Publication Date |
---|---|
MXPA05007348A true MXPA05007348A (es) | 2005-10-05 |
Family
ID=32717985
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MXPA05007348A MXPA05007348A (es) | 2003-01-06 | 2004-01-06 | Derivados de polimeros solubles en agua tiol-selectivos. |
Country Status (10)
Country | Link |
---|---|
US (5) | US7910661B2 (es) |
EP (1) | EP1581582B2 (es) |
JP (1) | JP4490413B2 (es) |
KR (2) | KR101207247B1 (es) |
AT (1) | ATE485331T1 (es) |
AU (1) | AU2004204136B2 (es) |
CA (1) | CA2509939C (es) |
DE (1) | DE602004029646D1 (es) |
MX (1) | MXPA05007348A (es) |
WO (1) | WO2004063250A1 (es) |
Families Citing this family (58)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2004060965A2 (en) * | 2002-12-31 | 2004-07-22 | Nektar Therapeutics Al, Corporation | Hydrolytically stable maleimide-terminated polymers |
US7432331B2 (en) | 2002-12-31 | 2008-10-07 | Nektar Therapeutics Al, Corporation | Hydrolytically stable maleimide-terminated polymers |
KR101207247B1 (ko) * | 2003-01-06 | 2012-12-03 | 넥타르 테라퓨틱스 | 티올-선택성 수용성 중합체 유도체 |
CN1767857A (zh) * | 2003-02-26 | 2006-05-03 | 尼克塔治疗亚拉巴马公司 | 聚合物-因子ⅷ部分共轭物 |
AU2005222641B2 (en) | 2004-03-15 | 2011-04-07 | Nektar Therapeutics | Polymer-based compositions and conjugates of HIV entry inhibitors |
WO2006053299A2 (en) | 2004-11-12 | 2006-05-18 | Bayer Healthcare Llc | Site-directed modification of fviii |
AU2005318984B2 (en) * | 2004-12-21 | 2011-12-01 | Nektar Therapeutics | Stabilized polymeric thiol reagents |
WO2006110776A2 (en) | 2005-04-12 | 2006-10-19 | Nektar Therapeutics Al, Corporation | Polyethylene glycol cojugates of antimicrobial agents |
ATE425204T1 (de) * | 2005-08-26 | 2009-03-15 | Novo Nordisk As | Verfahren zur modifizierung eines makromolekularen systems |
EP2364735A3 (en) | 2005-12-16 | 2012-04-11 | Nektar Therapeutics | Branched PEG conjugates of GLP-1 |
US7743730B2 (en) * | 2005-12-21 | 2010-06-29 | Lam Research Corporation | Apparatus for an optimized plasma chamber grounded electrode assembly |
JP2007209543A (ja) * | 2006-02-09 | 2007-08-23 | Hidetoshi Tsuchida | 表面修飾アルブミンからなる固相膜および酸素吸着膜 |
CN103030801B (zh) * | 2006-02-21 | 2015-07-22 | 尼克塔治疗公司 | 嵌段可降解聚合物及由其制备的轭合物 |
US9101670B2 (en) | 2006-04-07 | 2015-08-11 | Nektar Therapeutics | Conjugates of an anti-TNF-α antibody |
KR100819064B1 (ko) * | 2006-12-19 | 2008-04-04 | (재)대구경북과학기술연구원 | 생분자 고정화 링커 |
EP2192914A4 (en) * | 2007-08-20 | 2014-05-07 | Belrose Pharma Inc | POLYMER BINDERS CONTAINING PYRIDYL DISULFIDE GROUPS |
US7847019B2 (en) * | 2007-10-15 | 2010-12-07 | California Institute Of Technology | Functionalized polymers using protected thiols |
EP2095829A1 (en) | 2008-02-27 | 2009-09-02 | LEK Pharmaceuticals D.D. | Selenium containing modifying agents and conjugates |
EP2280734B1 (en) * | 2008-04-24 | 2014-02-26 | Cantab Biopharmaceuticals Patents Limited | Factor ix conjugates with extended half-lives |
WO2009139905A2 (en) * | 2008-05-16 | 2009-11-19 | Nektar Therapeutics | Conjugates of a cholinesterase moiety and a polymer |
JP2011520983A (ja) * | 2008-05-23 | 2011-07-21 | エンゾン ファーマシューティカルズ,インコーポレーテッド | オリゴヌクレオチドの送達のための細胞内遊離可能ジスルフィドリンカーを含有するポリマーシステム |
EP2323695B1 (en) * | 2008-08-19 | 2018-12-05 | Nektar Therapeutics | Complexes of small-interfering nucleic acids |
MX2011001887A (es) | 2008-08-22 | 2011-04-04 | Baxter Int | Derivados de bencil carbonato polimericos. |
WO2010042145A1 (en) * | 2008-09-19 | 2010-04-15 | Nektar Therapeutics | Polymer conjugates of glp-2-like peptides |
WO2010033205A1 (en) * | 2008-09-19 | 2010-03-25 | Nektar Therapeutics | Polymer conjugates of v681-like peptides |
WO2010033207A1 (en) | 2008-09-19 | 2010-03-25 | Nektar Therapeutics | Polymer conjugates of therapeutic peptides |
US20110171162A1 (en) * | 2008-09-19 | 2011-07-14 | Nektar Therapeutics | Polymer conjugates of thymosin alpha 1 peptides |
EP2340045B1 (en) * | 2008-09-19 | 2017-04-12 | Nektar Therapeutics | Polymer conjugates of protegrin peptides |
EP2340050A2 (en) * | 2008-09-19 | 2011-07-06 | Nektar Therapeutics | Polymer conjugates of aod-like peptides |
WO2010033222A2 (en) * | 2008-09-19 | 2010-03-25 | Netkar Therapeutics | Polymer conjugates of ziconotide peptides |
WO2010033218A1 (en) * | 2008-09-19 | 2010-03-25 | Nektar Therapeutics | Polymer conjugates of osteocalcin peptides |
WO2010033217A1 (en) * | 2008-09-19 | 2010-03-25 | Nektar Therapeutics | Polymer conjugates of cd-np peptides |
US20110165112A1 (en) * | 2008-09-19 | 2011-07-07 | Nektar Therapeutics | Polymer conjugates of c-peptides |
WO2010033223A1 (en) * | 2008-09-19 | 2010-03-25 | Nektar Therapeutics | Polymer conjugates of opioid growth factor peptides |
EP2340047A1 (en) * | 2008-09-19 | 2011-07-06 | Nektar Therapeutics | Polymer conjugates of kiss1 peptides |
US20110171312A1 (en) * | 2008-09-19 | 2011-07-14 | Nektar Therapeutics | Modified therapeutic peptides, methods of their preparation and use |
US20110318322A1 (en) | 2009-01-12 | 2011-12-29 | Nektar Therapeutics | Conjugates of a Lysosomal Enzyme Moiety and a Water Soluble Polymer |
HUE054318T2 (hu) | 2010-11-12 | 2021-08-30 | Nektar Therapeutics | IL-2 molekularész konjugátumai és polimer |
EP2694528A1 (en) * | 2011-04-05 | 2014-02-12 | Martin-Protean, LLC | Isolation of cysteine containing peptides |
US8815226B2 (en) | 2011-06-10 | 2014-08-26 | Mersana Therapeutics, Inc. | Protein-polymer-drug conjugates |
EP3228325A1 (en) | 2011-06-10 | 2017-10-11 | Mersana Therapeutics, Inc. | Protein-polymer-drug conjugates |
WO2013020079A2 (en) | 2011-08-04 | 2013-02-07 | Nektar Therapeutics | Conjugates of an il-11 moiety and a polymer |
EP2908861A4 (en) | 2012-10-19 | 2016-04-20 | Univ Cornell | BIOMIMETIC LIMIT LUBRICANTS FOR JOINT BASKET |
JP6661073B2 (ja) * | 2013-10-04 | 2020-03-11 | 学校法人東京薬科大学 | 新規化合物、その製造方法及びその用途 |
EP3054991B1 (en) | 2013-10-11 | 2019-04-03 | Mersana Therapeutics, Inc. | Protein-polymer-drug conjugates |
JP6427564B2 (ja) | 2013-10-11 | 2018-11-21 | アサナ・バイオサイエンシズ,リミテッド・ライアビリティ・カンパニー | タンパク質−ポリマー−薬物共役体 |
GB201401133D0 (en) | 2014-01-23 | 2014-03-12 | Renephra Ltd | Fluid extraction device, applicator device and associated methods |
EP3114138B1 (en) | 2014-03-05 | 2021-11-17 | Pfizer Inc. | Improved muteins of clotting factor viii |
MA39711A (fr) | 2014-04-03 | 2015-10-08 | Nektar Therapeutics | Conjugués d'une fraction d'il-15 et d'un polymère |
WO2016074030A1 (en) * | 2014-11-10 | 2016-05-19 | Spinal Developments Pty Ltd, A.T.F. The Spinesr Unit Trust | Rod reduction device |
US20160151511A1 (en) | 2014-12-02 | 2016-06-02 | Antriabio, Inc. | Proteins and protein conjugates with increased hydrophobicity |
MX2017014586A (es) | 2015-06-04 | 2018-03-09 | Antriabio Inc | Pegilacion de aminas para la preparacion de conjugados de proteinas especificos de un sitio. |
EP3463308B1 (en) * | 2016-06-01 | 2021-12-01 | Servier IP UK Limited | Formulations of polyalkylene oxide-asparaginase and methods of making and using the same |
CN107952064B (zh) * | 2016-10-14 | 2023-10-20 | 江苏豪森药业集团有限公司 | 含有聚乙二醇洛塞那肽的药物制剂及其制备方法 |
JP7101939B2 (ja) | 2017-03-30 | 2022-07-19 | 日油株式会社 | ジスルフィドリンカーを有する分解性ポリエチレングリコール誘導体 |
GB201721503D0 (en) | 2017-12-20 | 2018-01-31 | Univ Essex | Modified globin proteins |
CA3128035A1 (en) | 2020-08-13 | 2022-02-13 | Bioasis Technologies, Inc. | Combination therapies for delivery across the blood brain barrier |
AT524137A2 (de) | 2020-08-26 | 2022-03-15 | Pke Holding Ag | Tragbare Vorrichtung zur Steuerung eines Brandfalles |
Family Cites Families (28)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB707709A (en) † | 1951-04-02 | 1954-04-21 | Albert Boehringer | Process for the production of n-[-a:-g-dihydroxy--a:-a-dimethyl-butyryl]--a-alanine--a-mercaptoethylamide |
US3005853A (en) † | 1959-06-22 | 1961-10-24 | California Research Corp | Preparation of mercaptan and sulfide derivatives thereof |
US3063971A (en) † | 1959-06-22 | 1962-11-13 | California Research Corp | Polygycol sulfide-linked block copolymers |
EP0040506B1 (en) † | 1980-05-21 | 1986-08-20 | Teijin Limited | Reactive polymer and process for the preparation thereof |
JPS5730724A (en) † | 1980-07-31 | 1982-02-19 | Teijin Ltd | Polymer having disulfide bond in molecule and its preparation |
JPS63230086A (ja) † | 1987-03-17 | 1988-09-26 | Nitto Electric Ind Co Ltd | 生理活性物質固定用担体 |
US4958368A (en) † | 1988-10-31 | 1990-09-18 | Gte Mobilnet Incorporated | Customer activation system |
US4929706A (en) † | 1988-11-02 | 1990-05-29 | W. R. Grace & Co.-Conn. | Cell growth enhancers and/or antibody production stimulators comprising chemically modified hydrophilic polyurea-urethane prepolymers and polymers |
US5516703A (en) | 1993-08-20 | 1996-05-14 | The University Of Utah | Coating of hydrophobic surfaces to render them protein resistant while permitting covalent attachment of specific ligands |
AU6953294A (en) † | 1993-05-20 | 1994-12-20 | Regents Of The University Of California, The | Macromolecular contrast media for mr imaging |
US5446090A (en) | 1993-11-12 | 1995-08-29 | Shearwater Polymers, Inc. | Isolatable, water soluble, and hydrolytically stable active sulfones of poly(ethylene glycol) and related polymers for modification of surfaces and molecules |
US5932462A (en) | 1995-01-10 | 1999-08-03 | Shearwater Polymers, Inc. | Multiarmed, monofunctional, polymer for coupling to molecules and surfaces |
US5741715A (en) * | 1995-05-30 | 1998-04-21 | Roche Diagnostic Systems, Inc. | Quinidine immunoassay and reagents |
US5672662A (en) * | 1995-07-07 | 1997-09-30 | Shearwater Polymers, Inc. | Poly(ethylene glycol) and related polymers monosubstituted with propionic or butanoic acids and functional derivatives thereof for biotechnical applications |
TW520297B (en) † | 1996-10-11 | 2003-02-11 | Sequus Pharm Inc | Fusogenic liposome composition and method |
AU9187498A (en) † | 1997-10-03 | 1999-04-27 | Star Micronics Co., Ltd. | Image formation apparatus, image formation methods and plate making method |
WO1999018069A1 (fr) † | 1997-10-03 | 1999-04-15 | Star Micronics Co., Ltd. | Derives d'acide maleique, intermediaires de derives d'acide maleique, et leurs procedes de preparation |
US6258774B1 (en) | 1998-03-19 | 2001-07-10 | University Of Medicine And Dentistry Of New Jersey | Carrier for in vivo delivery of a therapeutic agent |
US6495136B1 (en) * | 1998-03-26 | 2002-12-17 | The Procter & Gamble Company | Proteases having modified amino acid sequences conjugated to addition moieties |
JP3880262B2 (ja) † | 1998-11-02 | 2007-02-14 | 株式会社カネカ | 水不溶化再生コラーゲン繊維の製造方法 |
ATE290564T1 (de) * | 1999-06-17 | 2005-03-15 | Univ Gent | Funktionsfähige poly-alpha-aminosäurederivate zur modifizierung von biologisch wirksamen stoffen und deren herstellung |
CA2380050A1 (en) † | 1999-07-22 | 2001-02-01 | University Of Medicine And Dentistry Of New Jersey | Materials and processes for controlled release of thioamide moiety-containing therapeutic agents by linking to thiol-containing polymers |
US6413507B1 (en) | 1999-12-23 | 2002-07-02 | Shearwater Corporation | Hydrolytically degradable carbamate derivatives of poly (ethylene glycol) |
KR100346994B1 (ko) † | 2000-01-11 | 2002-07-31 | 한국과학기술연구원 | 술폰산화 폴리에틸렌옥사이드가 결합된 생체적합성 의료용금속 재료 및 이의 제조 방법 |
TW593427B (en) | 2000-12-18 | 2004-06-21 | Nektar Therapeutics Al Corp | Synthesis of high molecular weight non-peptidic polymer derivatives |
ES2308032T5 (es) * | 2002-12-31 | 2017-04-24 | Nektar Therapeutics | Derivados poliméricos de ácido maleámico y sus bioconjugados |
WO2004060965A2 (en) * | 2002-12-31 | 2004-07-22 | Nektar Therapeutics Al, Corporation | Hydrolytically stable maleimide-terminated polymers |
KR101207247B1 (ko) | 2003-01-06 | 2012-12-03 | 넥타르 테라퓨틱스 | 티올-선택성 수용성 중합체 유도체 |
-
2004
- 2004-01-06 KR KR1020117031376A patent/KR101207247B1/ko active IP Right Grant
- 2004-01-06 MX MXPA05007348A patent/MXPA05007348A/es active IP Right Grant
- 2004-01-06 AT AT04700409T patent/ATE485331T1/de not_active IP Right Cessation
- 2004-01-06 CA CA2509939A patent/CA2509939C/en not_active Expired - Lifetime
- 2004-01-06 EP EP04700409.8A patent/EP1581582B2/en not_active Expired - Lifetime
- 2004-01-06 DE DE602004029646T patent/DE602004029646D1/de not_active Expired - Lifetime
- 2004-01-06 JP JP2006500996A patent/JP4490413B2/ja not_active Expired - Lifetime
- 2004-01-06 US US10/753,047 patent/US7910661B2/en active Active
- 2004-01-06 AU AU2004204136A patent/AU2004204136B2/en not_active Expired
- 2004-01-06 KR KR1020057012633A patent/KR101177340B1/ko active IP Right Grant
- 2004-01-06 WO PCT/US2004/001190 patent/WO2004063250A1/en active Application Filing
-
2010
- 2010-10-21 US US12/909,755 patent/US20110034643A1/en not_active Abandoned
-
2012
- 2012-11-19 US US13/681,357 patent/US8722032B2/en not_active Expired - Lifetime
-
2014
- 2014-03-28 US US14/229,547 patent/US9040658B2/en not_active Expired - Lifetime
-
2015
- 2015-04-23 US US14/694,160 patent/US9333267B2/en not_active Expired - Lifetime
Also Published As
Publication number | Publication date |
---|---|
AU2004204136B2 (en) | 2008-10-09 |
US20130079555A1 (en) | 2013-03-28 |
US20150224207A1 (en) | 2015-08-13 |
KR101177340B1 (ko) | 2012-08-30 |
JP4490413B2 (ja) | 2010-06-23 |
EP1581582B2 (en) | 2017-06-07 |
KR20120007080A (ko) | 2012-01-19 |
CA2509939C (en) | 2013-05-21 |
EP1581582A1 (en) | 2005-10-05 |
CA2509939A1 (en) | 2004-07-29 |
WO2004063250A1 (en) | 2004-07-29 |
KR20050090074A (ko) | 2005-09-12 |
US7910661B2 (en) | 2011-03-22 |
KR101207247B1 (ko) | 2012-12-03 |
US8722032B2 (en) | 2014-05-13 |
DE602004029646D1 (en) | 2010-12-02 |
US20050014903A1 (en) | 2005-01-20 |
ATE485331T1 (de) | 2010-11-15 |
US20110034643A1 (en) | 2011-02-10 |
AU2004204136A1 (en) | 2004-07-29 |
US20140330041A1 (en) | 2014-11-06 |
US9040658B2 (en) | 2015-05-26 |
JP2006517600A (ja) | 2006-07-27 |
EP1581582B1 (en) | 2010-10-20 |
US9333267B2 (en) | 2016-05-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MXPA05007348A (es) | Derivados de polimeros solubles en agua tiol-selectivos. | |
HK1173169A1 (en) | Dimercaptan terminated polythioether polymers and methods for making and using the same | |
BR0108555A (pt) | Composições de polìmero com constância de propriedades aperfeiçoada | |
HK1210627A1 (en) | Preparing crude biological estracts using protease, suitable for preparing cdna cdna | |
WO2004082622A3 (en) | Retinoid replacements and opsin agonists and methods for the use thereof | |
WO2007092829A3 (en) | Stabilized compositions of proteins having a free thiol moiety | |
NO20090047L (no) | Anti-DLL4-antistoffer og fremgangsmater for anvendelse av disse | |
EP1721933A4 (en) | COMPOSITION CONTAINING A WATER SOLUBLE AMPHOTERIC POLYMER | |
WO2006083275A3 (en) | Variable lymphocyte receptors, related polypeptides and nucleic acids, and uses thereof | |
WO2005087793A3 (en) | Immunostimulatory compositions and uses thereof | |
CA2597065C (en) | Compositions and methods related to soluble g-protein coupled receptors (sgpcrs) | |
EP1578930A4 (en) | CNGH0004 POLYPEPTIDES, ANTIBODIES, COMPOSITIONS, METHODS AND USES | |
WO2007136893A3 (en) | Anti-fgf19 antibodies and methods using same | |
AU2002350592A1 (en) | Ph-sensitive polymer | |
WO2007028110A3 (en) | Methods for using and identifying modulators of delta-like 4 | |
NO20043245L (no) | Bindingsproteiner som biosensorer | |
ATE494012T1 (de) | Stabilisierte polymer-thiol-reagenzien | |
EP1623011A4 (en) | IL-23P40-SPECIFIC IMMUNOGLOBIN DERIVED PROTEINS, COMPOSITIONS, METHODS AND USES | |
DE602006018856D1 (de) | Neue nutrazeutika-zusammensetzungen | |
BR0211617A (pt) | Partìculas inorgânicas e métodos de fabricação | |
WO2007075438A3 (en) | Polypeptides comprising unnatural amino acids, methods for their production and uses therefor | |
WO2005047471A3 (en) | Improved fret efficiency methods | |
WO2005116252A3 (en) | Methods for evaluating ribonucleotide sequences | |
ATE425734T1 (de) | Dentalzusammensetzungen mit oxiran-monomeren | |
WO2008094945A3 (en) | Compounds and methods for modulating protein expression |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
GB | Transfer or rights | ||
FG | Grant or registration |